Sheffield Dad Joins Team to Raise Awareness of Rare Cancer

Sheffield Teaching Hospitals NHS

Our neuroendocrine tumour (NETS) team and patient representative David Corbin came together on World Neuroendocrine Cancer Day last week to raise awareness with patients, visitors and colleagues.

The team shared information and raised awareness of this complex and often difficult to diagnose cancer.

NETs are tumours that develop in the cells of the neuroendocrine system (the system which produces hormones and releases them into the bloodstream).

Sheffield is a European Neuroendocrine Tumour Society (ENETS) Centre of Excellence and the only centre in Yorkshire to offer radionuclide therapy, a specialist treatment that directly targets cancer cells.

'I'd never heard of it'

|David underwent two sugeries and continues to take medications to manage his rare condition on an ongoing basis

David, 34, from Doncaster, was diagnosed in 2019.

He said: "It's really important that we raise awareness because when I was first diagnosed I had no idea what it was and had never heard of it. It is a rare cancer and symptoms can be missed.

"My wife was pregnant with our first child and I'd had fatigue, stomach issues, localised pain and coughing. By the time it was diagnosed it had spread from my small bowel to my neck and my spine."

David, who works in HR and has two boys aged six and three, has subsequently undergone two surgeries and his condition is now classed as stable, with his symptoms and medication being managed on an ongoing basis.

"We are really lucky to have a centre of excellence here in Sheffield. The treatment has been fantastic and very patient focused, really working around what works for you and your life. Having a really supportive network of health professions is very important.

Raising awareness

|David helped raise awareness of neuroendocrine cancer at the Royal Hallamshire Hospital last week

"I now run a Sheffield support group through the department which is really good for sharing experiences and supporting each other."

Dr Alia Munir, Consultant Endocrinologist at Sheffield Teaching Hospitals NHS Foundation Trust, added:

"NETS symptoms can be quite general and so awareness is key. It is sometimes known as the 'invisible cancer.' Unfortunately, over half of patients with NETS are diagnosed after it has metastasised. We want to raise awareness among the public and health professionals to improve recognition and understanding of this disease and help to improve the speed of diagnosis and treatment."

Related information

< back

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.